User profiles for B.C. Trapnell
Bruce C. Trapnell, MDProfessor of Medicine and Pediatrics, University of Cincinnati Verified email at cchmc.org Cited by 25210 |
Pulmonary alveolar proteinosis
BC Trapnell, JA Whitsett, K Nakata - New England Journal of …, 2003 - Mass Medical Soc
In acquired pulmonary alveolar proteinosis, lipids and proteins accumulate within the
alveoli because alveolar macrophages cannot catabolize surfactants. Surprisingly, alveolar …
alveoli because alveolar macrophages cannot catabolize surfactants. Surprisingly, alveolar …
Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense
BC Trapnell, JA Whitsett - Annual review of physiology, 2002 - annualreviews.org
▪ Abstract Recent studies in transgenic mice have revealed important insights into the roles
of GM-CSF in regulation of surfactant homeostasis and lung host defense. Interruption of the …
of GM-CSF in regulation of surfactant homeostasis and lung host defense. Interruption of the …
Pulmonary alveolar proteinosis
BC Trapnell, K Nakata, F Bonella, I Campo… - Nature Reviews …, 2019 - nature.com
Pulmonary alveolar proteinosis (PAP) is a syndrome characterized by the accumulation of
alveolar surfactant and dysfunction of alveolar macrophages. PAP results in progressive …
alveolar surfactant and dysfunction of alveolar macrophages. PAP results in progressive …
In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium
MA Rosenfeld, K Yoshimura, BC Trapnell, K Yoneyama… - Cell, 1992 - cell.com
Direct transfer of the normal cystic fibrosis (CF) transmembrane conductance regulator (CFTR)
gene to airway epitheiium was evaluated using a replicationdeficient recombinant …
gene to airway epitheiium was evaluated using a replicationdeficient recombinant …
[HTML][HTML] Efficacy and safety of sirolimus in lymphangioleiomyomatosis
…, HS Lee, JP Krischer, BC Trapnell - … England Journal of …, 2011 - Mass Medical Soc
Background Lymphangioleiomyomatosis (LAM) is a progressive, cystic lung disease in
women; it is associated with inappropriate activation of mammalian target of rapamycin (mTOR) …
women; it is associated with inappropriate activation of mammalian target of rapamycin (mTOR) …
Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
N Mittereder, KL March, BC Trapnell - Journal of virology, 1996 - Am Soc Microbiol
… toshev, and BC Trapnell. 1994. Evaluation of the efficacy and safety of in vitro, adenovirus-mediated
transfer of the human cystic fibrosis transmembrane conductance regulator cDNA. …
transfer of the human cystic fibrosis transmembrane conductance regulator cDNA. …
[PDF][PDF] GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU. 1
…, ZC Chroneos, M Yoshida, JA Whitsett, BC Trapnell - Immunity, 2001 - cell.com
… PU.1 protein levels in AMs in vivo and that the 2 Correspondence: bruce.trapnell@chmcc.org …
BC (2001). Alveolar macrophage deficiency in M-CSF-deficient, group B streptococcal …
BC (2001). Alveolar macrophage deficiency in M-CSF-deficient, group B streptococcal …
Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA
CS Chu, BC Trapnell, S Curristin, GR Cutting… - Nature …, 1993 - nature.com
… Trapnell, BC etal. Down-regulation of cystic fibrosis gene mRNAtranscript levels and
induction of the cystic fibrosis chloride secretory phenotype in epithelial cells by phorbol ester. J. …
induction of the cystic fibrosis chloride secretory phenotype in epithelial cells by phorbol ester. J. …
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
…, BS Kirschner, AS Patel, D Ziring, BC Trapnell… - The Lancet, 2017 - thelancet.com
Background Stricturing and penetrating complications account for substantial morbidity and
health-care costs in paediatric and adult onset Crohn's disease. Validated models to predict …
health-care costs in paediatric and adult onset Crohn's disease. Validated models to predict …
Diffuse lung disease in young children: application of a novel classification scheme
…, AS Brody, LM Nogee, BC Trapnell… - American journal of …, 2007 - atsjournals.org
Rationale: Considerable confusion exists regarding nomenclature, classification, and
management of pediatric diffuse lung diseases due to the relative rarity and differences in the …
management of pediatric diffuse lung diseases due to the relative rarity and differences in the …